| Disease Term | Human Homologs | Mouse Homologs | Mouse Models | Homology Source | |||
  | acrodermatitis enteropathica | SLC39A4* | Slc39a4* | 1 model | Alliance of Genome Resources | ||
| Albright's hereditary osteodystrophy | GNAS* | Gnas* | 2 models | Alliance of Genome Resources | |||
| atransferrinemia | TF* | Trf* | 2 models | Alliance of Genome Resources | |||
| autosomal dominant hypocalcemia 1 | CASR* | Casr* | 2 models | Alliance of Genome Resources | |||
| autosomal dominant hypocalcemia 2 | GNA11* | Gna11* | 2 models | Alliance of Genome Resources | |||
| hemochromatosis type 1 | HFE* | Hfe* | 13 models | Alliance of Genome Resources | |||
| hemochromatosis type 2A | HJV* | Hjv* | 2 models | Alliance of Genome Resources | |||
| hemochromatosis type 2B | HAMP* | Hamp*, Hamp2 | 1 model | Alliance of Genome Resources | |||
| hemochromatosis type 3 | TFR2* | Tfr2* | 2 models | Alliance of Genome Resources | |||
| hemochromatosis type 4 | SLC40A1* | Slc40a1* | 3 models | Alliance of Genome Resources | |||
| hyperkalemic periodic paralysis | SCN4A* | Scn4a* | 4 models | Alliance of Genome Resources | |||
| hypokalemic periodic paralysis | CACNA1S* | Cacna1s* | 2 models | Alliance of Genome Resources | |||
| Menkes disease | LOX* | Lox* | 1 model | Alliance of Genome Resources | |||
| Menkes disease | ATP7A* | Atp7a* | 10 models | Alliance of Genome Resources | |||
| molybdenum cofactor deficiency type A | MOCS1* | Mocs1* | 1 model | Alliance of Genome Resources | |||
| molybdenum cofactor deficiency type B | MOCS2* | Mocs2* | 1 model | Alliance of Genome Resources | |||
| pseudohypoparathyroidism | GNAS* | Gnas* | 2 models | Alliance of Genome Resources | |||
| pseudopseudohypoparathyroidism | GNAS* | Gnas* | 1 model | Alliance of Genome Resources | |||
| renal hypomagnesemia 3 | CLDN16* | Cldn16* | 2 models | Alliance of Genome Resources | |||
| Wilson disease | ATP7B* | Atp7b* | 3 models | Alliance of Genome Resources | |||
| | Albright's hereditary osteodystrophy | PTHLH | Pthlh* | 1 model | Alliance of Genome Resources | ||
| hemochromatosis | HMOX1 | Hmox1* | 1 model | Alliance of Genome Resources | |||
| hemochromatosis | B2M | B2m* | 1 model | Alliance of Genome Resources | |||
| hypokalemic periodic paralysis | SCN4A | Scn4a* | 1 model | Alliance of Genome Resources | |||
| pseudohypoparathyroidism | GNAS-AS1 | Gnasas1* | 2 models | Alliance of Genome Resources | |||
| | autosomal dominant hypocalcemia | CASR* | Casr | Alliance of Genome Resources | |||
| familial periodic paralysis | KCNJ2* | Kcnj2 | Alliance of Genome Resources | ||||
| hemochromatosis | ALAS2* | Alas2 | Alliance of Genome Resources | ||||
| hemochromatosis | TNF* | Tnf | Alliance of Genome Resources | ||||
| hemochromatosis | TFR2* | Tfr2 | Alliance of Genome Resources | ||||
| hemochromatosis | HJV* | Hjv | Alliance of Genome Resources | ||||
| hemochromatosis | HFE* | Hfe | Alliance of Genome Resources | ||||
| hemochromatosis | HAMP* | Hamp, Hamp2 | Alliance of Genome Resources | ||||
| hemochromatosis type 1 | BMP2* | Bmp2 | Alliance of Genome Resources | ||||
| hemochromatosis type 5 | FTH1* | Fth1 | Alliance of Genome Resources | ||||
| hypermanganesemia with dystonia 1 | SLC30A10* | Slc30a10 | Alliance of Genome Resources | ||||
| hypermanganesemia with dystonia 2 | SLC39A14* | Slc39a14 | Alliance of Genome Resources | ||||
| hypokalemic periodic paralysis | KCNE3* | Kcne3 | Alliance of Genome Resources | ||||
| intestinal hypomagnesemia 1 | TRPM6* | Trpm6 | Alliance of Genome Resources | ||||
| metal metabolism disorder | TRPM6* | Trpm6 | Alliance of Genome Resources | ||||
| molybdenum cofactor deficiency type C | GPHN* | Gphn | Alliance of Genome Resources | ||||
| occipital horn syndrome | ATP7A* | Atp7a | Alliance of Genome Resources | ||||
| primary hypomagnesemia | EGF* | Egf | Alliance of Genome Resources | ||||
| pseudohypoparathyroidism type IB | STX16* | Stx16 | Alliance of Genome Resources | ||||
| pseudohypoparathyroidism type IB | GNAS* | Gnas | Alliance of Genome Resources | ||||
| pseudohypoparathyroidism type IB | GNAS-AS1* | Gnasas1 | Alliance of Genome Resources | ||||
| renal hypomagnesemia 2 | FXYD2* | Fxyd2 | Alliance of Genome Resources | ||||
| renal hypomagnesemia 4 | EGF* | Egf | Alliance of Genome Resources | ||||
| renal hypomagnesemia 5 with ocular involvement | CLDN19* | Cldn19 | Alliance of Genome Resources | ||||
| renal hypomagnesemia 6 | CNNM2* | Cnnm2 | Alliance of Genome Resources | ||||
| renal hypomagnesemia 7, with or without dilated cardiomyopathy | RRAGD* | Rragd | Alliance of Genome Resources | ||||
Excel File
|
Transgenes and other genome features developed in mice to model this disease.
|
|||
| Disease Term | Transgenes and Other Genome Features | Mouse Models | |
| pseudohypoparathyroidism | Del(2Nespas-Gnas)1Hju | 1 model | |
| renal hypomagnesemia 3 | Tg(RNU6-RNAi:Cldn16)551Dago | 1 model | |